Osteoporosis diagnosis and therapy according to the 2010 guidelines;Leitliniengerechte diagnostik und therapie der osteoporose 2010

Zeitschrift fur Rheumatologie

Volumn 69, Issue 4, 2010, Pages 329-339

  Braun, J ^a   Pfeilschifter, J ^b  

^a RHEUMAZENTRUM RUHRGEBIET   (Germany)

^b ALFRIED KRUPP KRANKENHAUS   (Germany)

Author keywords

Bone mineral density; Calcium; Fractures; Osteoporosis; Vitamin D

Indexed keywords

CALCIUM; VITAMIN D;

CALCIUM INTAKE; DISABILITY; FALLING; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; LONG TERM CARE; MUSCLE FUNCTION; OSTEOPOROSIS; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SENESCENCE; VERTEBRA FRACTURE; ARTICLE; DIET SUPPLEMENTATION; FRACTURE; GERMANY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; RHEUMATOLOGY; STANDARD;

CALCIUM; DELIVERY OF HEALTH CARE; DIETARY SUPPLEMENTS; FRACTURES, BONE; GERMANY; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; OSTEOPOROSIS; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; RHEUMATOLOGY; VITAMIN D;

EID: 77955570839     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-010-0623-3     Document Type: Review

References (23)

1. Consensus Development Conference (1993) Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646-656
2. Hiligsmann M, Ethgen O, Richy F et al (2008) Utility values associated with osteoporotic fracture: A systematic review of the literature. Calcif Tissue Int 82:288-292
3. Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375-382 (Pubitemid 38953182)
4. Blake GM, Fogelman I (2007) Role of dual-energy x-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom 10:102-110 (Pubitemid 46199277)
5. Tervo T, Nordström P, Neovius M et al (2008) Constant adaptation of bone to current physical activity level in men: A 12-year longitudinal study. J Clin Endocrinol Metab 93:4873-4879
6. Steingrimsdottir L, Gunnarsson O, Indridason OS et al (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency and calcium intake. JAMA 294:2336-2341
7. Bolland MJ, Barber PA, Doughty RN et al (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:262-266
8. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S-1086S
9. Bauer DC, Ettinger B, Nevitt MC et al (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561-568
10. Orstavik RE, Haugeberg G, Mowinckel P et al (2004) Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 164 (4):420-425
11. Kanis JA, Johansson H, Oden A et al (2004) A metaanalysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19 (6):893-899
12. Staa TP van, Geusens P, Bijlsma JW et al (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54 (10):3104-3112 (Pubitemid 44622079)
13. Bianchi G, Sambrook P (2008) Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures. Curr Med Res Opin 24:2669-2677
14. DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen. Osteologie 18:304-328, http://www.dv-osteologie. org/dvo-leitlinien/dvo-leitlinie-2009
15. McCloskey EV, Johansson H, Oden A et al (2008) Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int 20:811-817
16. Saag KG, Shane E, Boonen S et al (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357:2028-2039
17. Seeman E (2007) Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 41:308-317
18. Curtis JR, Westfall AO, Cheng H et al (2008) Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporos Int 19:1613-1620
19. Gallagher A, Rietbrock S, Olson M et al (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569-1575
20. Ito Z, Harada A, Matsui Y et al (2006) Can you diagnose for vertebral fracture correctly by plain X-ray? Osteoporos Int 17:1584-1591
21. Pfeilschifter J (2007) Schmerztherapie bei Osteoporose. Allgemeinarzt 19:32-37
22. Smith MR, Egerdie B, Hernández Toriz N et al (2009) Denosumab halt prostate cancer study group. Denosumab in men receiving androgendeprivation therapy for prostate cancer. N Engl J Med 361 (8):745-755
23. Cummings SR, San Martin J, Mc-Clung MR et al (2009) Freedom trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361 (8):756-765